Conclusion Of Non-Exclusive Discount Agreements Pursuant To Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Tadalafil (G04Be08), Only Medicinal Products With The Indication Benign Prostatic Syndrome As Part Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 101402444

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient Tadalafil (G04BE08), only medicinal products with the indication of benign prostatic syndromewithin the period from March 1, 2025 to February 28, 2027 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list in accordance with Section 35 Paragraph 5a SGB V (medicines for children) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimittel

Gt Ref Id - 101402444

Deadline - Dec 31, 2026